Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Orphan Drugs
Urgent collective action to meet the challenge of this pandemic crisis:...
Christopher Garrison
-
March 30, 2020
Corbyn’s Compulsory Licenses. Will they work?
Ellen 't Hoen
-
September 26, 2019
Dutch Minister of Health writes open letter to pharma, threatens to...
Ellen 't Hoen
-
August 28, 2019
EU Review of Pharmaceutical Incentives: Recommendations for Change
Ellen 't Hoen
-
June 3, 2019
Strong call for transparency on medicine prices, cost of R&D at...
Ellen 't Hoen
-
April 19, 2019
Faced with unreasonable medicines prices, the Netherlands introduces pharmacy exemption in...
Ellen 't Hoen
-
February 22, 2019
Time to put a stop to the abuse of orphan drug...
Ellen 't Hoen
-
January 9, 2019
New Dutch Foundation to Address High Medicines Pricing Announces Plan to...
Ellen 't Hoen
-
August 25, 2018
Pharmaceutical Pricing Hostages
Ellen 't Hoen
-
September 13, 2017
High medicines prices in Europe – do not Brexit the people
Ellen 't Hoen
-
July 21, 2016
This work is licensed under Creative Commons.